At the news
? NEUTRALIMPACT 2/10 8-K filed Jun 26, 2026 at 17:07 ET
Phibro Animal Health appointed Daniel (Dani) Bendheim as CEO and President effective July 1, 2026, with an employment agreement including a base salary of $850,000, target bonus of 50% of base, and a grant of 300,000 performance-based RSUs vesting based on stock price targets ($70–$100+ by June 30, 2031). This is a routine leadership transition with standard compensation terms and no financial data or red flags.
- Daniel Bendheim appointed CEO and President effective July 1, 2026
- Base salary of $850,000 per year with target bonus of 50% of base salary
- Initial grant of 300,000 performance-based RSUs vesting based on 90-day average stock price from $70 to $100+ by June 30, 2031
- Annual time-vesting RSU target value of approximately 50% of base salary
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access